AWARE: Management of ADHD in Autism Spectrum Disorder
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Daniel Coury, MD
Nationwide Children's Hospital
Principal Investigator - Karen Kuhlthau, PhD
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta, Glenrose Rehabilitation Hospital
Edmonton, Canada
Lonnie Zwaigenbaum, MDRecruiting - Holland Bloorview Kids Rehabilitation Hospital
Toronto, Canada
Danielle Baribeau, MD, PhDRecruiting
- University of California, Irvine
Irvine, California, United States
Peter Chung, MDRecruiting - Children'S Hospital Los Angeles
Los Angeles, California, United States
Kathryn Smith, RN, MN, DrPHRecruiting - Maine Medical Center
Portland, Maine, United States
Danielle Sipsock, MDRecruiting - Massachusetts General Hospital Lurie Center for Autism
Boston, Massachusetts, United States
Ann Neumeyer, MDRecruiting - University of Rochester
Rochester, New York, United States
Lynn Cole, DNPRecruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Julia Anixt, MDRecruiting - Nationwide Children'S Hospital
Columbus, Ohio, United States
Eric Butter, PhDRecruiting - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Carlyn Glatts, MDRecruiting - University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Benjamin HandenRecruiting - Prisma Health Upstate
Greenville, South Carolina, United States
Karen L Ratliff-Schaub, MDRecruiting - University of Virginia
Charlottesville, Virginia, United States
Richard Stevenson, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2023
- Primary completion
- 1 Jan 2027
- Completion
- 30 Dec 2027
- Last update posted
- 22 Oct 2026
- Registered enrollment
- 500
- Registry id
- NCT05916339
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.